Silicon Laboratories (NASDAQ:SLAB) Releases Earnings Results, Hits Estimates

Silicon Laboratories (NASDAQ:SLAB) announced its quarterly earnings data on Tuesday. The semiconductor company reported ($0.11) EPS for the quarter, hitting analysts’ consensus estimates of ($0.11), RTT News reports. Silicon Laboratories had a negative return on equity of 12.60% and a negative net margin of 46.93%. The firm had revenue of $166.25 million during the quarter, compared to analyst estimates of $166.09 million. During the same period last year, the company posted ($1.19) EPS. The business’s quarterly revenue was up 91.4% compared to the same quarter last year. Silicon Laboratories updated its Q1 2025 guidance to -0.190-0.010 EPS and its Q1 guidance to $(0.19)-0.01 EPS.

Silicon Laboratories Price Performance

NASDAQ SLAB traded down $2.23 during mid-day trading on Tuesday, hitting $132.57. The company’s stock had a trading volume of 356,663 shares, compared to its average volume of 322,161. Silicon Laboratories has a 52-week low of $94.00 and a 52-week high of $154.91. The firm has a market capitalization of $4.30 billion, a P/E ratio of -17.94 and a beta of 1.16. The stock’s fifty day simple moving average is $126.96 and its two-hundred day simple moving average is $116.33.

Insider Buying and Selling

In other news, Director William G. Bock sold 2,000 shares of the stock in a transaction on Wednesday, January 22nd. The shares were sold at an average price of $140.77, for a total transaction of $281,540.00. Following the transaction, the director now owns 32,115 shares in the company, valued at $4,520,828.55. This represents a 5.86 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 1.72% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

Several research firms have recently issued reports on SLAB. StockNews.com upgraded Silicon Laboratories to a “sell” rating in a research note on Friday, November 8th. KeyCorp lifted their price target on shares of Silicon Laboratories from $115.00 to $160.00 and gave the company an “overweight” rating in a research note on Wednesday, January 22nd. Benchmark reiterated a “hold” rating on shares of Silicon Laboratories in a report on Tuesday, November 5th. Stifel Nicolaus increased their target price on shares of Silicon Laboratories from $135.00 to $145.00 and gave the stock a “buy” rating in a report on Monday, January 6th. Finally, JPMorgan Chase & Co. reduced their price objective on shares of Silicon Laboratories from $150.00 to $135.00 and set an “overweight” rating for the company in a research report on Tuesday, November 5th. One research analyst has rated the stock with a sell rating, six have assigned a hold rating and five have issued a buy rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Hold” and an average price target of $133.56.

About Silicon Laboratories

Silicon Laboratories Inc, a fabless semiconductor company, provides various analog-intensive mixed-signal solutions in the United States, China, Taiwan, and internationally. The company's products include wireless microcontrollers and sensor products. Its products are used in various electronic products in a range of applications for the industrial Internet of Things (IoT), including industrial automation and control, smart buildings, access control, HVAC control, and industrial wearables and power tools; smart cities applications, such as smart metering, smart street lighting, renewable energy, electric vehicle supply equipment, and smart agriculture; commercial IoT applications, including smart lighting, asset tracking, electronic shelf labels, theft protection, and enterprise access points; smart home applications, comprising home automation/security systems, smart speakers, smart lighting, HVAC control, smart cameras, smart appliances, smart home sensing, smart locks, and window/blind controls; and connected health applications, including diabetes management, consumer health and fitness, elderly care, patient monitoring, and activity tracking; as well as in commercial building automation, consumer electronics, and medical instrumentation.